Free Cash Flow

The company's revenue skyrocketed, but SEC filings reveal a story of significant liquidity risks and a bold gamble on the booming wellness market.

A landmark partnership between Grassroots Carbon and Colorado State University is set to validate soil carbon removal, impacting ranchers and corporations.

With strong growth in key sectors but weakness in others, Plexus management faces a pivotal moment at the upcoming Raymond James investor conference.

BioNexus Gene Lab appoints Matthew Barsing to lead its Chemrex subsidiary, signaling a strategic overhaul from industrial chemicals to biotech and advanced tech.

BioVie faces a pivotal moment, touting breakthrough drugs for Alzheimer's and cirrhosis while navigating clinical setbacks and financial pressures.

ITF Therapeutics will unveil 10 new data presentations on its Duchenne therapy, DUVYZAT, offering critical new insights on long-term safety and efficacy.

With key investor conferences looming, Phathom Pharmaceuticals is set to showcase strong VOQUEZNA sales and a clear path to 2026 profitability.

With its newly approved VIZZ eye drop, LENZ Therapeutics is wooing investors, aiming to capture a slice of the massive, underserved presbyopia market.

Montreal firm's advanced titanium powder will fuel next-gen aerospace innovation, highlighting its role in a critical, high-growth global market.

RCI faces a Nasdaq deadline amid late financial reports linked to a NY indictment. Can strong profits and a new CEO team navigate the regulatory storm?

With its stock under pressure despite strong results, Box will use a key conference to prove its AI-powered content platform is the future of enterprise work.

Nutrien's leadership prepares for two major investor conferences, facing questions on fertilizer markets, critical minerals, and global food security.

As Home Instead names its 10 Care Pros of the Year, the awards highlight both profound human compassion and the urgent need to address a critical caregiver shortage.

The chemical giant's dramatic dividend cut ends a 14-year growth streak, raising questions about sector health and long-term investor returns.

The miner posted a $2.9B free cash flow and a record $1.8B dividend payout, fueled by high gold prices and strategic growth in its 2025 earnings.

As Sectra prepares its nine-month report, all eyes are on its performance as a key indicator for the converging medical IT and cybersecurity sectors.

Lyft CFO Erin Brewer will address investors at the Bernstein TMT Forum, outlining the company's strategy for sustained profitability and future growth.

Weave posts strong 2025 results, leveraging AI and key partnerships with CareCredit and the ADA to redefine the healthcare practice front office.

With a securitization 5x oversubscribed, Kiavi unlocks $1.2B in new funding, proving investor confidence in its AI-powered real estate lending platform.

AB Volvo’s election committee backs continuity by proposing the re-election of its chairman and board, navigating a major strategic shift despite a key departure.